Anika Therapeutics, Inc. (ANIK)
USD 16.04
(-3.49%)
USD 16.04
(-3.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 166.66 Million | 156.23 Million | 147.79 Million | 130.45 Million | 114.61 Million | 105.55 Million |
| Cost of Revenue | 63.57 Million | 62.66 Million | 64.85 Million | 61.43 Million | 28.74 Million | 31.28 Million |
| Gross Profit | 103.08 Million | 93.57 Million | 82.94 Million | 69.02 Million | 85.86 Million | 74.27 Million |
| Operating Expenses | 191.47 Million | 112.97 Million | 101.42 Million | 83.49 Million | 51.61 Million | 52.52 Million |
| Selling, General and Administrative Expenses | 95.84 Million | 84.79 Million | 74.09 Million | 60.06 Million | 34.95 Million | 34.33 Million |
| Research and Development Expenses | 32.68 Million | 28.18 Million | 27.32 Million | 23.43 Million | 16.66 Million | 18.19 Million |
| Other Expenses | 75.93 Million | - | - | - | - | - |
| Cost and Expenses | 254.3 Million | 175.63 Million | 166.27 Million | 144.92 Million | 80.36 Million | 83.8 Million |
| Operating Income | -87.63 Million | -19.4 Million | -18.48 Million | -14.46 Million | 34.24 Million | 21.74 Million |
| Interest Expense | - | 654 Thousand | - | - | - | - |
| Income Tax Expense | -2.66 Million | -3.88 Million | -1.7 Million | -4.64 Million | 8.92 Million | 4.48 Million |
| Earnings before Tax | -85.32 Million | -18.74 Million | 2.42 Million | -28.62 Million | 36.12 Million | 23.2 Million |
| Net Income | -82.66 Million | -14.85 Million | 4.13 Million | -23.98 Million | 27.19 Million | 18.72 Million |
| Earnings Per Share Basic | -5.64 | -1.02 | 0.29 | -1.69 | 1.93 | 1.30 |
| Earnings Per Share Diluted | -5.64 | -1.02 | 0.28 | -1.69 | 1.89 | 1.27 |
| Weighted Average Shares Outstanding | 14.65 Million | 14.56 Million | 14.4 Million | 14.22 Million | 14.12 Million | 14.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.65 Million | 14.56 Million | 14.63 Million | 14.22 Million | 14.37 Million | 14.68 Million |
| Gross Margin | 0.62 | 0.60 | 0.56 | 0.53 | 0.75 | 0.70 |
| EBIT Margin | 0.02 | -0.12 | -0.27 | -0.00 | 0.30 | 0.21 |
| Profit Margin | -0.50 | -0.10 | 0.03 | -0.18 | 0.24 | 0.18 |
| EBITDA | 2.51 Million | -4.91 Million | 2.61 Million | -12.82 Million | 34.24 Million | 27.65 Million |
| Earnings Before Tax Margin | -0.53 | -0.12 | -0.13 | -0.11 | 0.30 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 38.75 Million | 41.92 Million | 40.52 Million | 166.66 Million | 42.97 Million | 41.46 Million |
| Cost of Revenue | 37.31 Million | 14.55 Million | 15.89 Million | 63.57 Million | 16.64 Million | 16.52 Million |
| Gross Profit | 1.44 Million | 27.36 Million | 24.62 Million | 103.08 Million | 26.32 Million | 24.94 Million |
| Operating Expenses | 26.35 Million | 27.2 Million | 29.69 Million | 128.53 Million | 27.92 Million | 32.61 Million |
| Selling, General and Administrative Expenses | 19.11 Million | 19.8 Million | 21.52 Million | - | 20.33 Million | 24.82 Million |
| Research and Development Expenses | 7.24 Million | 7.39 Million | 8.16 Million | - | 7.58 Million | 7.79 Million |
| Other Expenses | 3.1 Million | - | - | - | - | - |
| Cost and Expenses | 63.66 Million | 41.76 Million | 45.58 Million | 192.11 Million | 44.56 Million | 49.13 Million |
| Operating Income | -24.91 Million | 161 Thousand | -5.06 Million | -25.44 Million | -1.59 Million | -7.67 Million |
| Interest Expense | - | - | 592 Thousand | 2.31 Million | 1.21 Million | - |
| Income Tax Expense | 2.3 Million | 844 Thousand | 43 Thousand | -2.66 Million | -204 Thousand | -463 Thousand |
| Earnings before Tax | -27.61 Million | 756 Thousand | -4.47 Million | -85.32 Million | -63.2 Million | -7.03 Million |
| Net Income | -29.91 Million | -88 Thousand | -4.51 Million | -82.66 Million | -63 Million | -6.57 Million |
| Earnings Per Share Basic | -2.03 | -0.01 | -0.31 | - | -4.30 | -0.45 |
| Earnings Per Share Diluted | -2.03 | -0.01 | -0.31 | - | -4.30 | -0.45 |
| Weighted Average Shares Outstanding | 14.76 Million | 14.83 Million | 14.69 Million | 14.65 Million | 14.64 Million | 14.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.76 Million | 14.83 Million | 14.69 Million | 14.65 Million | 14.64 Million | 14.63 Million |
| Gross Margin | 0.04 | 0.65 | 0.61 | 0.62 | 0.61 | 0.60 |
| EBIT Margin | -0.66 | 0.05 | -0.06 | - | 0.05 | -0.19 |
| Profit Margin | -0.77 | -0.00 | -0.11 | -0.50 | -1.47 | -0.16 |
| EBITDA | -25.56 Million | 2.21 Million | -2.46 Million | - | 2 Million | -7.67 Million |
| Earnings Before Tax Margin | -0.64 | 0.00 | -0.12 | -0.15 | -0.04 | -0.19 |
6118
BANASFN
300332
600469
600871
2432